Compounds > cidofovir anhydrous
Page last updated: 2024-08-24

cidofovir anhydrous and Vitreous Hemorrhage

cidofovir anhydrous has been researched along with Vitreous Hemorrhage in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dunn, JP; Foster, G; Jabs, DA; Kuppermann, BD; Martin, DF; Van Natta, M; Zong, A1

Trials

2 trial(s) available for cidofovir anhydrous and Vitreous Hemorrhage

ArticleYear
Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
    Retina (Philadelphia, Pa.), 2004, Volume: 24, Issue:1

    Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Anesthesia, General; Anesthesia, Local; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Female; Ganciclovir; Humans; Infusions, Intravenous; Intraoperative Complications; Male; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Prospective Studies; Visual Acuity; Vitreous Hemorrhage

2004
The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
    American journal of ophthalmology, 2001, Volume: 131, Issue:4

    Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Double-Blind Method; Drug Evaluation; Drug Implants; Female; Ganciclovir; Humans; Infusions, Parenteral; Kidney; Male; Organophosphonates; Organophosphorus Compounds; Survival Rate; Treatment Outcome; Uveitis; Visual Acuity; Vitreous Hemorrhage

2001